<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>TI</div>
TROVAGENE INC is trading at 3.76 as of the 5th of July 2020, which is -9.62 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.76. TROVAGENE INC has less than a 17 % chance of experiencing some financial distress in the next two years of operation and had a very solid performance during the last 30 days. Equity ratings for TROVAGENE INC DL are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 6th of April 2020 and ending today, the 5th of July 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

19 100 

   Odds of Distress


Cardiff Oncology, Inc., a clinical-stage, oncology therapeutic company, develops drugs to treat various types of cancer, including leukemia, lymphomas, and solid tumors. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California. TROVAGENE INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12 people. more on TROVAGENE INC
ChairmanThomas AdamsView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of TROVAGENE INC available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Cautious HoldOvervalued
TROVAGENE INC DL (XE7C) is traded on Frankfurt Stock Exchange in Germany and employs 12 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 85.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TROVAGENE INC's market, we take the total number of its shares issued and multiply it by TROVAGENE INC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. TROVAGENE INC DL operates under Healthcare sector and is part of Biotechnology industry. The entity has 17.25 M outstanding shares. The company has accumulated about 9.28 M in cash with (13.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
Check TROVAGENE INC Probability Of Bankruptcy

Ownership Allocation (%)

TROVAGENE Stock Price Odds Analysis

Odds Down 3.76HorizonTargetOdds Up 3.76
95.54%30 days
Based on a normal probability distribution, the odds of TROVAGENE INC to move above the current price in 30 days from now is nearly 4.44 (This TROVAGENE INC DL probability density function shows the probability of TROVAGENE INC Stock to fall within a particular range of prices over 30 days) .


TROVAGENE Stock Against Markets

Did you try this?

Run Focused Opportunities Now


Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module
Check out Your Current Watchlist. Please also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page